EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CT radiomics for noninvasively predicting NQO1 expression levels in hepatocellular carcinoma

Zenglei He iD, Xiaoyong Shen, Bin Wang, Li Xu, Qi Ling iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0290900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Zenglei He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR Chi…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using noninvasive radiomics to predict pathological biomarkers is an innovative work worthy of exploration. This retrospective cohort study aimed to analyze the correlation between NAD(P)H quinone oxidoreductase 1 (NQO1) expression levels and the prognosis of patients with hepatocellular carcinoma (HCC) and to construct radiomic models to predict the expression levels of NQO1 prior to surgery. Data of patients with HCC from The Cancer Genome Atlas (TCGA) and the corresponding arterial phase-enhanced CT images from The Cancer Imaging Archive were obtained for prognosis analysis, radiomic feature extraction, and model development. In total, 286 patients with HCC from TCGA were included. According to the cut-off value calculated using R, patients were divided into high-expression (n = 143) and low-expression groups (n = 143). Kaplan–Meier survival analysis showed that higher NQO1 expression levels were significantly associated with worse prognosis in patients with HCC ( p = 0.017). Further multivariate analysis confirmed that high NQO1 expression was an independent risk factor for poor prognosis (HR = 1.761, 95% CI: 1.136−2.73, p = 0.011). Based on the arterial phase-enhanced CT images, six radiomic features were extracted, and a new bi-regional radiomics model was established, which could noninvasively predict higher NQO1 expression with good performance. The area under the curve (AUC) was 0.9079 (95% CI 0.8127–1.0000). The accuracy, sensitivity, and specificity were 0.86, 0.88, and 0.84, respectively, with a threshold value of 0.404. The data verification of our center showed that this model has good predictive efficiency, with an AUC of 0.8791 (95% CI 0.6979–1.0000). In conclusion, there existed a significant correlation between the CT image features and the expression level of NQO1, which could indirectly reflect the prognosis of patients with HCC. The predictive model based on arterial phase CT imaging features has good stability and diagnostic efficiency and is a potential means of identifying the expression level of NQO1 in HCC tissues before surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansRetrospective StudiesArchivesNADH, NADPH OxidoreductasesTomography, X-Ray ComputedNAD(P)H Dehydrogenase (Quinone)

Substanzen

NADH, NADPH OxidoreductasesNQO1 protein, humanNAD(P)H Dehydrogenase (Quinone)

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.
  • Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.

ORCID-Profile: Zenglei He, Qi Ling

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

He, Z., Shen, X., Wang, B., Xu, L., & Ling, Q. (2023). CT radiomics for noninvasively predicting NQO1 expression levels in hepatocellular carcinoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0290900

Vancouver

He Z, Shen X, Wang B, Xu L, Ling Q. CT radiomics for noninvasively predicting NQO1 expression levels in hepatocellular carcinoma. PLOS ONE. 2023. doi:10.1371/journal.pone.0290900

BibTeX
@article{He2023,
  author = {He, Zenglei and Shen, Xiaoyong and Wang, Bin and Xu, Li and Ling, Qi},
  title = {CT radiomics for noninvasively predicting NQO1 expression levels in hepatocellular carcinoma},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0290900}
}
Kostenlos starten →